Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Jayashree Kalpathy-Cramer

Concepts (388)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Retinopathy of Prematurity
32
2023
111
5.780
Why?
Artificial Intelligence
28
2024
144
4.460
Why?
Brain Neoplasms
23
2024
966
3.710
Why?
Glioblastoma
15
2024
250
3.580
Why?
Image Processing, Computer-Assisted
21
2024
684
3.290
Why?
Algorithms
36
2024
1469
2.460
Why?
Machine Learning
19
2023
315
2.440
Why?
Diagnostic Imaging
18
2022
278
2.350
Why?
Natural Language Processing
7
2023
72
2.080
Why?
Magnetic Resonance Imaging
39
2024
3039
1.960
Why?
Information Storage and Retrieval
8
2015
106
1.840
Why?
Radiology
8
2023
137
1.720
Why?
Glioma
8
2022
285
1.670
Why?
Neuroimaging
7
2022
249
1.650
Why?
Uterine Cervical Neoplasms
5
2024
213
1.450
Why?
Radiotherapy Planning, Computer-Assisted
5
2016
117
1.380
Why?
Software
9
2020
526
1.210
Why?
Image Interpretation, Computer-Assisted
12
2019
224
1.110
Why?
Papillomavirus Infections
4
2024
261
1.070
Why?
Tomography, X-Ray Computed
15
2023
2272
1.030
Why?
Humans
143
2024
114045
1.000
Why?
Telemedicine
7
2023
662
0.980
Why?
Ophthalmology
5
2023
75
0.850
Why?
ROC Curve
13
2022
441
0.850
Why?
Privacy
1
2023
28
0.840
Why?
Radiology Information Systems
4
2022
27
0.840
Why?
Retina
6
2023
263
0.840
Why?
Solitary Pulmonary Nodule
3
2021
19
0.830
Why?
Severity of Illness Index
8
2021
2537
0.830
Why?
Diagnostic Techniques, Ophthalmological
3
2018
35
0.820
Why?
Infant, Newborn
32
2023
5038
0.780
Why?
Reproducibility of Results
26
2023
2764
0.750
Why?
Ophthalmoscopy
7
2023
30
0.700
Why?
Crowdsourcing
1
2020
14
0.700
Why?
Breast Neoplasms
5
2024
1846
0.690
Why?
Medicine
1
2021
102
0.680
Why?
Gestational Age
15
2023
761
0.650
Why?
Stroke
3
2023
1019
0.630
Why?
Retinal Vessels
5
2020
50
0.620
Why?
Retinal Vein
4
2021
13
0.580
Why?
Isocitrate Dehydrogenase
1
2017
38
0.580
Why?
Lung Neoplasms
5
2021
2159
0.560
Why?
Sensitivity and Specificity
13
2023
1690
0.560
Why?
Databases, Factual
8
2021
1125
0.550
Why?
Retrospective Studies
23
2023
12521
0.540
Why?
Radiologists
3
2022
35
0.540
Why?
Tumor Burden
4
2023
258
0.530
Why?
Receptors, Vascular Endothelial Growth Factor
1
2016
103
0.530
Why?
Peripheral Arterial Disease
4
2023
381
0.520
Why?
Phenylurea Compounds
1
2016
81
0.520
Why?
Quinolines
1
2016
129
0.510
Why?
Gallbladder Neoplasms
3
2011
11
0.500
Why?
Neoplasm Recurrence, Local
2
2019
850
0.490
Why?
Radiography, Thoracic
5
2022
150
0.490
Why?
Pattern Recognition, Automated
5
2023
67
0.480
Why?
Benchmarking
6
2024
161
0.480
Why?
Delivery of Health Care
1
2021
828
0.470
Why?
Female
50
2024
59324
0.470
Why?
Chemoradiotherapy
6
2018
187
0.460
Why?
Subtraction Technique
1
2014
24
0.460
Why?
White Matter
3
2023
105
0.450
Why?
Radiation Oncology
2
2014
75
0.450
Why?
Photography
6
2021
88
0.450
Why?
Retinal Artery
3
2021
15
0.450
Why?
Vocabulary, Controlled
1
2014
41
0.440
Why?
Fundus Oculi
4
2023
40
0.440
Why?
Phantoms, Imaging
7
2023
123
0.440
Why?
Multimodal Imaging
1
2014
89
0.430
Why?
Datasets as Topic
5
2021
98
0.400
Why?
Clinical Competence
2
2016
882
0.400
Why?
Male
47
2024
55396
0.400
Why?
Survival Analysis
4
2016
1206
0.390
Why?
Contrast Media
9
2020
347
0.390
Why?
Internet
2
2014
591
0.380
Why?
Cerebral Blood Volume
3
2020
4
0.380
Why?
Radiotherapy, Conformal
1
2011
68
0.370
Why?
Brain
8
2021
2355
0.370
Why?
Adrenoleukodystrophy
2
2023
4
0.360
Why?
Proportional Hazards Models
4
2011
1078
0.360
Why?
Head and Neck Neoplasms
5
2020
427
0.350
Why?
Middle Aged
27
2024
26605
0.340
Why?
Radiographic Image Interpretation, Computer-Assisted
2
2023
98
0.340
Why?
Aged
26
2024
18969
0.340
Why?
Medical Informatics
4
2020
89
0.340
Why?
Endovascular Procedures
2
2023
267
0.310
Why?
Early Detection of Cancer
4
2024
305
0.300
Why?
Database Management Systems
1
2008
47
0.300
Why?
User-Computer Interface
4
2015
141
0.300
Why?
Lung
6
2022
3521
0.300
Why?
Radiotherapy, Adjuvant
1
2008
182
0.300
Why?
Adult
25
2024
30375
0.300
Why?
Prognosis
9
2024
3315
0.290
Why?
Automation
5
2020
74
0.290
Why?
Mass Screening
3
2023
979
0.270
Why?
Diffusion Magnetic Resonance Imaging
2
2018
83
0.260
Why?
Antineoplastic Agents
1
2016
1875
0.260
Why?
Radiography
5
2022
803
0.260
Why?
Rectal Neoplasms
2
2021
122
0.250
Why?
Endoscopy, Gastrointestinal
1
2007
201
0.250
Why?
Neonatal Screening
4
2023
151
0.250
Why?
Oropharyngeal Neoplasms
2
2015
39
0.250
Why?
Reference Standards
7
2021
159
0.230
Why?
Observer Variation
3
2018
298
0.230
Why?
Forecasting
3
2019
331
0.230
Why?
Adenocarcinoma in Situ
1
2023
1
0.220
Why?
Cervix Uteri
1
2023
44
0.220
Why?
Postoperative Care
2
2019
223
0.220
Why?
Prostatic Neoplasms
3
2020
913
0.220
Why?
Infant, Premature
7
2023
478
0.220
Why?
Mammography
2
2023
101
0.220
Why?
Imaging, Three-Dimensional
4
2023
511
0.220
Why?
Uterine Cervical Dysplasia
1
2023
42
0.210
Why?
Statistics as Topic
2
2014
291
0.210
Why?
Oxygen
2
2021
851
0.210
Why?
Ranibizumab
1
2023
18
0.210
Why?
Radiotherapy, Intensity-Modulated
4
2016
124
0.210
Why?
Diagnosis, Computer-Assisted
2
2021
64
0.210
Why?
Documentation
2
2015
166
0.210
Why?
Neovascularization, Pathologic
3
2024
280
0.200
Why?
Long QT Syndrome
1
2023
59
0.200
Why?
Biomarkers
4
2018
3397
0.200
Why?
Cohort Studies
6
2022
4883
0.200
Why?
Rheumatic Diseases
1
2022
49
0.200
Why?
Computer Communication Networks
2
2020
32
0.200
Why?
Quality Assurance, Health Care
2
2014
308
0.200
Why?
Neoplasms
5
2020
2086
0.190
Why?
Diverticulitis
1
2021
7
0.190
Why?
Racism
1
2023
99
0.190
Why?
Hospital Units
1
2021
23
0.180
Why?
Infant
10
2023
7943
0.180
Why?
Intestinal Obstruction
1
2021
39
0.180
Why?
Biomarkers, Tumor
3
2016
1032
0.180
Why?
India
1
2021
134
0.180
Why?
Musculoskeletal System
1
2021
42
0.180
Why?
Neoplasm Grading
2
2020
241
0.180
Why?
Breast Density
1
2020
3
0.180
Why?
Precision Medicine
2
2016
335
0.180
Why?
Tibial Meniscus Injuries
1
2021
43
0.180
Why?
Dacarbazine
3
2015
99
0.180
Why?
Biomedical Research
2
2019
582
0.180
Why?
Microcirculation
2
2017
133
0.170
Why?
Cerebellar Neoplasms
1
2022
130
0.170
Why?
Health Information Exchange
1
2020
11
0.170
Why?
Perfusion Imaging
1
2020
51
0.170
Why?
Lung Injury
1
2022
192
0.170
Why?
Radiometry
1
2020
41
0.170
Why?
Brain Ischemia
1
2023
297
0.170
Why?
Hematopoietic Stem Cell Transplantation
2
2023
519
0.170
Why?
Carcinoma, Squamous Cell
2
2015
577
0.170
Why?
Hyperemia
1
2020
45
0.170
Why?
Medical Records Systems, Computerized
2
2013
88
0.170
Why?
Medulloblastoma
1
2022
172
0.170
Why?
Predictive Value of Tests
3
2021
1791
0.170
Why?
Appendicitis
1
2021
112
0.170
Why?
Drug Resistance, Neoplasm
1
2024
636
0.170
Why?
Signal Processing, Computer-Assisted
2
2017
131
0.170
Why?
Antibodies, Monoclonal, Humanized
1
2024
660
0.170
Why?
Positron Emission Tomography Computed Tomography
1
2020
67
0.170
Why?
Risk Factors
8
2023
8614
0.170
Why?
Brain Diseases
1
2021
124
0.170
Why?
Area Under Curve
4
2021
273
0.170
Why?
Low Back Pain
1
2021
93
0.170
Why?
Vascular Endothelial Growth Factor A
2
2023
496
0.160
Why?
Blood-Brain Barrier
2
2017
106
0.160
Why?
Antineoplastic Agents, Alkylating
2
2018
68
0.160
Why?
Aneurysm, Ruptured
1
2019
34
0.160
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2019
1356
0.160
Why?
Capillary Permeability
1
2019
137
0.160
Why?
Age Determination by Skeleton
1
2018
16
0.160
Why?
Prospective Studies
7
2023
6195
0.160
Why?
Colonic Neoplasms
1
2021
212
0.160
Why?
Cone-Beam Computed Tomography
1
2018
24
0.150
Why?
Treatment Outcome
7
2023
9049
0.150
Why?
Linear Models
1
2021
768
0.150
Why?
Global Health
1
2021
284
0.150
Why?
Intracranial Aneurysm
1
2019
90
0.150
Why?
Ventricular Dysfunction, Right
1
2021
221
0.150
Why?
Arteries
2
2019
246
0.150
Why?
Medical Record Linkage
1
2018
53
0.150
Why?
Bayes Theorem
2
2016
327
0.150
Why?
Diagnosis, Differential
3
2019
1331
0.140
Why?
Respiratory Insufficiency
1
2021
286
0.140
Why?
Chronic Pain
1
2021
208
0.140
Why?
Patient Readmission
1
2022
607
0.140
Why?
Preoperative Period
1
2017
102
0.140
Why?
Gadolinium
1
2017
73
0.140
Why?
Polysaccharides, Bacterial
1
2017
66
0.140
Why?
Gray Matter
1
2018
67
0.140
Why?
Acute Kidney Injury
1
2023
637
0.140
Why?
Skin Diseases, Genetic
1
2016
10
0.130
Why?
Pharyngeal Muscles
1
2016
3
0.130
Why?
Nasopharyngeal Neoplasms
1
2016
13
0.130
Why?
SEER Program
3
2011
195
0.130
Why?
Blood Vessels
1
2017
179
0.130
Why?
Patient-Specific Modeling
1
2016
37
0.130
Why?
Aged, 80 and over
5
2018
6306
0.130
Why?
Liver Cirrhosis
1
2017
227
0.130
Why?
Tumor Microenvironment
1
2018
428
0.130
Why?
Models, Biological
3
2019
1611
0.130
Why?
Angiogenesis Inhibitors
2
2016
213
0.130
Why?
National Cancer Institute (U.S.)
3
2020
40
0.130
Why?
Vascular Malformations
1
2016
48
0.130
Why?
Blood Volume Determination
1
2015
5
0.130
Why?
Longitudinal Studies
2
2019
2384
0.130
Why?
Fibrosis
1
2017
452
0.120
Why?
Positron-Emission Tomography
4
2021
260
0.120
Why?
Cranial Irradiation
1
2015
66
0.120
Why?
Birth Weight
3
2023
439
0.120
Why?
Physical Phenomena
1
2014
12
0.120
Why?
Radiation Injuries
1
2016
128
0.120
Why?
Organs at Risk
1
2014
30
0.120
Why?
Brachial Plexus
1
2014
28
0.120
Why?
Mutation
3
2024
3338
0.120
Why?
Administration, Oral
1
2016
725
0.120
Why?
Deglutition Disorders
1
2016
117
0.120
Why?
Young Adult
7
2018
10444
0.120
Why?
Chemoradiotherapy, Adjuvant
2
2011
40
0.110
Why?
Joint Instability
1
2016
163
0.110
Why?
Arteriovenous Malformations
1
2013
24
0.110
Why?
Computer-Assisted Instruction
1
2014
59
0.110
Why?
Optic Disk
1
2013
38
0.110
Why?
Computer Literacy
1
2013
6
0.110
Why?
Survival Rate
3
2018
1638
0.100
Why?
Health Information Systems
1
2013
16
0.100
Why?
Terminology as Topic
1
2014
186
0.100
Why?
Feasibility Studies
2
2014
735
0.100
Why?
Risk Assessment
3
2023
2958
0.100
Why?
Research Design
2
2014
919
0.100
Why?
Computer Simulation
4
2017
873
0.100
Why?
Workload
1
2013
131
0.100
Why?
Otorhinolaryngologic Neoplasms
1
2011
2
0.100
Why?
Nomograms
1
2011
41
0.090
Why?
Muscle, Skeletal
1
2020
1468
0.090
Why?
Emergency Service, Hospital
1
2021
1815
0.090
Why?
Support Vector Machine
2
2021
34
0.090
Why?
Exercise
1
2020
1642
0.090
Why?
Liver
1
2017
1633
0.080
Why?
North America
2
2021
255
0.080
Why?
Periodicals as Topic
1
2012
180
0.080
Why?
Papillomaviridae
2
2023
101
0.080
Why?
Child
7
2022
18401
0.080
Why?
Lower Extremity
2
2023
334
0.080
Why?
Oregon
1
2008
65
0.080
Why?
Follow-Up Studies
3
2024
4392
0.080
Why?
Total Quality Management
1
2008
61
0.080
Why?
Electronic Health Records
1
2015
799
0.070
Why?
Protein Kinase Inhibitors
1
2013
784
0.070
Why?
MEDLINE
1
2008
22
0.070
Why?
Breast
2
2019
138
0.070
Why?
Dilatation, Pathologic
2
2018
55
0.070
Why?
Monte Carlo Method
2
2017
136
0.070
Why?
United States
4
2020
12137
0.070
Why?
Cluster Analysis
1
2007
452
0.070
Why?
Clinical Protocols
2
2019
232
0.060
Why?
Critical Illness
2
2021
640
0.060
Why?
Intensive Care Units, Neonatal
2
2018
176
0.060
Why?
Physicians
1
2013
765
0.060
Why?
Kinetics
2
2019
1547
0.060
Why?
Colposcopy
1
2023
15
0.060
Why?
Brain Infarction
1
2023
22
0.050
Why?
Troponin T
1
2023
49
0.050
Why?
Bias
2
2014
178
0.050
Why?
DNA Helicases
1
2024
133
0.050
Why?
Models, Theoretical
2
2021
513
0.050
Why?
X-Rays
1
2022
30
0.050
Why?
Data Curation
1
2022
11
0.050
Why?
Smartphone
1
2023
73
0.050
Why?
Logistic Models
2
2021
1829
0.050
Why?
Adrenal Glands
1
2022
66
0.050
Why?
Vagina
1
2024
146
0.050
Why?
Antineoplastic Agents, Immunological
1
2024
152
0.050
Why?
Quinazolines
2
2013
240
0.050
Why?
Health Services
1
2022
103
0.050
Why?
Limb Salvage
1
2022
51
0.050
Why?
Neoadjuvant Therapy
1
2024
305
0.050
Why?
Case-Control Studies
2
2019
3003
0.050
Why?
Genetic Therapy
1
2023
256
0.050
Why?
Receptors, GABA
1
2021
8
0.050
Why?
Utilization Review
1
2021
34
0.050
Why?
Edema
1
2022
119
0.050
Why?
Seizures
1
2024
337
0.050
Why?
Clinical Trials as Topic
2
2016
926
0.050
Why?
Nepal
1
2021
19
0.050
Why?
Incidence
2
2020
2314
0.050
Why?
Massachusetts
1
2021
134
0.050
Why?
Abdomen
1
2021
99
0.040
Why?
Early Diagnosis
1
2021
217
0.040
Why?
Models, Statistical
2
2016
595
0.040
Why?
Cell Cycle Proteins
1
2024
549
0.040
Why?
Disease Progression
2
2020
2371
0.040
Why?
Hematopoietic Stem Cells
1
2023
338
0.040
Why?
Internationality
1
2021
143
0.040
Why?
Ankle
1
2020
70
0.040
Why?
Chemotherapy, Cancer, Regional Perfusion
1
2019
4
0.040
Why?
Nuclear Proteins
1
2024
591
0.040
Why?
Genomics
1
2024
631
0.040
Why?
Arthroscopy
1
2021
199
0.040
Why?
Medical Oncology
1
2021
229
0.040
Why?
Infant, Low Birth Weight
1
2020
124
0.040
Why?
Bevacizumab
1
2019
114
0.040
Why?
Hand Bones
1
2018
2
0.040
Why?
Risk
1
2021
810
0.040
Why?
Ventricular Function, Right
1
2021
256
0.040
Why?
Quality Control
1
2019
143
0.040
Why?
Radiation Exposure
1
2019
41
0.040
Why?
Reference Values
1
2020
739
0.040
Why?
Hyperlipidemias
1
2019
121
0.040
Why?
Diabetic Retinopathy
1
2020
149
0.040
Why?
Consensus
1
2020
532
0.040
Why?
Hemizygote
1
2017
3
0.040
Why?
Carbon Tetrachloride
1
2017
6
0.040
Why?
Ecosystem
1
2022
500
0.040
Why?
Outpatients
1
2021
325
0.040
Why?
Half-Life
1
2017
141
0.040
Why?
Skull
1
2018
119
0.040
Why?
Chemotherapy, Adjuvant
1
2018
332
0.040
Why?
Diffusion
1
2017
119
0.040
Why?
Permeability
1
2017
149
0.040
Why?
Respiration, Artificial
1
2021
528
0.040
Why?
Asymptomatic Diseases
1
2017
75
0.040
Why?
Tissue Distribution
1
2017
285
0.040
Why?
Societies, Medical
1
2021
655
0.030
Why?
Information Dissemination
1
2019
185
0.030
Why?
Signal-To-Noise Ratio
1
2016
56
0.030
Why?
Expert Systems
1
2016
3
0.030
Why?
Intensive Care Units
1
2021
614
0.030
Why?
Prostate
1
2017
157
0.030
Why?
Transcription Factors
1
2024
1526
0.030
Why?
Perfusion
1
2016
147
0.030
Why?
Video Recording
1
2017
141
0.030
Why?
Palate, Soft
1
2016
10
0.030
Why?
Heart Ventricles
1
2021
723
0.030
Why?
Randomized Controlled Trials as Topic
1
2021
1204
0.030
Why?
Dose-Response Relationship, Radiation
1
2016
127
0.030
Why?
Magnetic Resonance Angiography
1
2017
221
0.030
Why?
Evaluation Studies as Topic
1
2016
167
0.030
Why?
Antineoplastic Protocols
1
2015
1
0.030
Why?
Cerebrovascular Circulation
1
2017
219
0.030
Why?
Platelet Count
1
2015
79
0.030
Why?
Molecular Imaging
1
2016
50
0.030
Why?
Radiotherapy Dosage
1
2016
243
0.030
Why?
Diffusion Tensor Imaging
1
2015
63
0.030
Why?
Motion
1
2015
92
0.030
Why?
Disease-Free Survival
1
2016
618
0.030
Why?
Comorbidity
1
2019
1447
0.030
Why?
Child, Preschool
2
2018
9114
0.030
Why?
Thoracic Neoplasms
1
2014
31
0.030
Why?
Mass Spectrometry
1
2017
622
0.030
Why?
Image Enhancement
1
2015
158
0.030
Why?
Carcinoma
1
2016
198
0.030
Why?
Adolescent
3
2018
17800
0.030
Why?
DNA Modification Methylases
1
2013
15
0.030
Why?
DNA Repair Enzymes
1
2013
23
0.030
Why?
Pandemics
1
2021
1310
0.030
Why?
Congresses as Topic
1
2015
193
0.030
Why?
Fluorescein Angiography
1
2013
104
0.030
Why?
Argentina
1
2013
14
0.030
Why?
Molecular Targeted Therapy
1
2016
347
0.030
Why?
Cross-Sectional Studies
1
2023
4402
0.030
Why?
Statistics, Nonparametric
1
2013
384
0.030
Why?
Smoking
1
2019
1382
0.020
Why?
Pregnancy
1
2023
5499
0.020
Why?
Hospitalization
1
2021
1762
0.020
Why?
Hemodynamics
1
2016
1015
0.020
Why?
Time Factors
1
2022
6077
0.020
Why?
Receptor Protein-Tyrosine Kinases
1
2013
224
0.020
Why?
Life Tables
1
2011
17
0.020
Why?
Effect Modifier, Epidemiologic
1
2011
12
0.020
Why?
Tumor Suppressor Proteins
1
2013
283
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2013
787
0.020
Why?
Hypertension
1
2019
1052
0.020
Why?
Diabetes Mellitus
1
2019
898
0.020
Why?
Pilot Projects
1
2015
1360
0.020
Why?
Polymerase Chain Reaction
1
2013
990
0.020
Why?
Educational Status
1
2013
408
0.020
Why?
Probability
1
2011
286
0.020
Why?
Lymphatic Metastasis
1
2011
275
0.020
Why?
Rats
1
2017
4913
0.020
Why?
Kaplan-Meier Estimate
1
2011
813
0.020
Why?
Ultrasonography
1
2012
635
0.020
Why?
Disease Models, Animal
1
2017
3498
0.020
Why?
PubMed
1
2008
10
0.020
Why?
Neoplasm Staging
1
2011
1162
0.020
Why?
Attitude of Health Personnel
1
2013
970
0.020
Why?
Internship and Residency
1
2014
920
0.020
Why?
Age Factors
1
2011
2885
0.010
Why?
Mice
1
2017
14843
0.010
Why?
Animals
1
2017
31565
0.010
Why?
Kalpathy-Cramer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)